Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Universita Degli Studi Di Milano Bicocca
Sponsor

Universita Degli Studi Di Milano Bicocca

Italy Piazza Dell'ateneo Nuovo 1, 20126 Milan, Italy

About the sponsor

Clinical research in glioblastoma focuses on treatment strategies for IDH-wildtype glioblastoma and imaging-based assessment of tumour control in the post-surgical setting.

  • High-grade glioma
  • Glioblastoma response evaluation
  • Radiographic disease assessment

The sponsor’s work in this area centres on therapeutic approaches used alongside established neuro-oncology care.

About Specializations

Universita Degli Studi Di Milano Bicocca runs clinical trials in conditions such as B-cell type acute leukaemia, Glioblastoma, Cholangitis sclerosing, Cognitive disorder, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

B-cell type acute leukaemia

Recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Glioblastoma

Recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Embonate
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Cholangitis sclerosing

Recruiting
Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Vancomycin
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Cognitive disorder

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Anaplastic large cell lymphoma T- and null-cell types

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lorlatinib
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Acute lymphocytic leukaemia

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.